Akari Therapeutics Plc Adr (AKTX)

Feb 11, 2026

Akari Therapeutics Participates in Virtual Investor “What This Means” Interview Discussing the Company’s Expanded ADC Pipeline - Chartmill

Feb 11, 2026

Feb 05, 2026

Akari Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial - Sahm

Feb 05, 2026

Feb 03, 2026

Akari Therapeutics (NASDAQ: AKTX) seeks approval for major warrant exercises - Stock Titan

Feb 03, 2026

Jan 26, 2026

Akari Therapeutics Files Key Patent and Unveils Second ADC Program AKTX-102 Targeting CEACAM5 Expressing Solid Tumors - Sahm

Jan 26, 2026

Jan 12, 2026

Curious about the stocks that are showing activity after the closing bell on Monday? - Chartmill

Jan 12, 2026

Jan 09, 2026

Akari Therapeutics Releases New CEO Corner Segment Highlighting 2025 Progress and Path to Clinical Transition In 2026 - GlobeNewswire Inc.

Jan 09, 2026

Jan 09, 2026

Akari Therapeutics Releases New CEO Corner Segment Highlighting 2025 Progress and Path to Clinical Transition In 2026 - Sahm

Jan 09, 2026

Jan 09, 2026

Akari Therapeutics to Present at the 2026 Biotech Showcase - Sahm

Jan 09, 2026

Dec 31, 2025

Why Vanda Pharmaceuticals Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Sahm

Dec 31, 2025

Dec 30, 2025

Akari Therapeutics Plc ADR (AKTX) Stock Sees a-0.57% Decrease - News Heater

Dec 30, 2025

Dec 30, 2025

Akari Therapeutics advances ADC oncology program with novel payload By Investing.com - Investing.com South Africa

Dec 30, 2025

Dec 30, 2025

Akari Therapeutics advances ADC oncology program with novel payload - Investing.com India

Dec 30, 2025

Dec 27, 2025

Operating cash flow per share of Akari Therapeutics Plc Sponsored ADR – FWB:CLA - TradingView — Track All Markets

Dec 27, 2025

Dec 27, 2025

AKTX SEC FilingsAkari Therapeutics Plc 10-K, 10-Q, 8-K Forms - Stock Titan

Dec 27, 2025

Dec 25, 2025

Short Interest in Akari Therapeutics PLC (NASDAQ:AKTX) Expands By 650.6% - Defense World

Dec 25, 2025

Dec 23, 2025

Akari begins GMP manufacturing of lead ADC program with WuXi XDC - Investing.com

Dec 23, 2025

Dec 23, 2025

Akari begins GMP manufacturing of lead ADC program with WuXi XDC By Investing.com - Investing.com South Africa

Dec 23, 2025

Dec 23, 2025

Akari Therapeutics Initiates GMP Manufacturing of AKTX-101 ADC Program to Support Phase 1 First-in-Human Clinical Trial - Sahm

Dec 23, 2025

Dec 18, 2025

Akari Therapeutics Releases Virtual Investor “What This Means” Segment - Sahm

Dec 18, 2025

Dec 17, 2025

Akari Therapeutics (Nasdaq: AKTX) sells 10M ADSs and issues new warrants - Stock Titan

Dec 17, 2025

Dec 16, 2025

Akari Therapeutics raises $5 million in at-market offering By Investing.com - Investing.com South Africa

Dec 16, 2025

Dec 16, 2025

Akari Therapeutics raises $5 million in at-market offering - Investing.com India

Dec 16, 2025

Dec 09, 2025

Akari Therapeutics stock rises on promising pancreatic cancer drug data By Investing.com - Investing.com South Africa

Dec 09, 2025

Dec 09, 2025

Akari Therapeutics stock rises on promising pancreatic cancer drug data - Investing.com

Dec 09, 2025

Dec 04, 2025

Views of Wall Street’s Leading Experts on Moderna Inc - setenews.com

Dec 04, 2025

Dec 04, 2025

Akari Therapeutics Provides Corporate Update and Highlights its ADC Payload Innovation Expected to Drive Value in New CEO Corner Segment - Sahm

Dec 04, 2025

Nov 26, 2025

Akari Therapeutics receives Nasdaq notice for minimum bid price non-compliance - Investing.com

Nov 26, 2025

Nov 26, 2025

Akari Therapeutics receives Nasdaq notice for minimum bid price non-compliance By Investing.com - Investing.com South Africa

Nov 26, 2025

Nov 25, 2025

Akari Therapeutics Announces Release of the Next CEO Corner Segment - Sahm

Nov 25, 2025

Nov 21, 2025

Tops & Flops Stocks - sharewise.com

Nov 21, 2025

Nov 18, 2025

Akari Therapeutics Appoints Biotech Finance Leader, Kameel D. Farag as Interim Chief Financial Officer - Finviz

Nov 18, 2025

Nov 18, 2025

Akari Therapeutics appoints Kameel Farag as interim CFO By Investing.com - Investing.com South Africa

Nov 18, 2025

Nov 18, 2025

Akari Therapeutics appoints Kameel Farag as interim CFO - Investing.com

Nov 18, 2025

Nov 17, 2025

[DEF 14A] Akari Therapeutics Plc Definitive Proxy Statement - Stock Titan

Nov 17, 2025

Nov 17, 2025

[S-1] Akari Therapeutics Plc Files IPO Registration Statement | AKTX SEC FilingForm S-1 - Stock Titan

Nov 17, 2025

Nov 14, 2025

Insiders Re-Evaluate Their US$1.81m Stock Purchase As Akari Therapeutics Falls To US$19m - Sahm

Nov 14, 2025

Nov 10, 2025

Why Akari Therapeutics Plc Depositary Receipt stock appeals to analystsWall Street Watch & Verified Momentum Stock Watchlist - newser.com

Nov 10, 2025

Nov 07, 2025

[PRE 14A] Akari Therapeutics Plc Preliminary Proxy Statement - Stock Titan

Nov 07, 2025

Nov 06, 2025

Akari Therapeutics Plc ADR (AKTX) looking to reclaim success with recent performance - setenews.com

Nov 06, 2025

Oct 30, 2025

Akari Therapeutics forms scientific advisory board with Dr. Hurvitz By Investing.com - Investing.com South Africa

Oct 30, 2025

Oct 30, 2025

Akari Therapeutics Announces Formation of Scientific Advisory Board and Inaugural Appointment of Renowned Medical Oncologist, Sara A. Hurvitz, MD, FACP - The Manila Times

Oct 30, 2025

Oct 25, 2025

What Wall Street predicts for Akari Therapeutics Plc Depositary Receipt stock priceMarket Performance Summary & Weekly Breakout Stock Alerts - newser.com

Oct 25, 2025

Oct 23, 2025

Akari Therapeutics launches CEO Corner to enhance investor communications By Investing.com - Investing.com India

Oct 23, 2025

Oct 16, 2025

Form 424B5 Akari Therapeutics Plc - StreetInsider

Oct 16, 2025

Oct 15, 2025

Akari Therapeutics stock falls after $2.5 million registered offering - Investing.com

Oct 15, 2025

Oct 15, 2025

Akari Therapeutics secures $2.5 million through registered offering - Investing.com India

Oct 15, 2025

Oct 15, 2025

$2.5M raise: Akari Therapeutics to issue 3,125,000 ADSs in registered direct offering - Stock Titan

Oct 15, 2025